Clear Street’s NeuroSense Therapeutics Ltd. Warrant NRSNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.4K | Sell |
63,685
-2,074
| -3% | -$1.32K | ﹤0.01% | 350 |
|
|
2025
Q1 | $13.5K | Buy |
65,759
+100
| +0.2% | +$21 | ﹤0.01% | 318 |
|
|
2024
Q4 | $28.9K | Sell |
65,659
-100
| -0.2% | -$44 | ﹤0.01% | 213 |
|
|
2024
Q3 | $9.87K | Buy |
65,759
+6,487
| +11% | +$974 | ﹤0.01% | 366 |
|
|
2024
Q2 | $12.2K | Buy |
59,272
+100
| +0.2% | +$21 | ﹤0.01% | 380 |
|
|
2024
Q1 | $24.9K | Sell |
59,172
-100
| -0.2% | -$42 | ﹤0.01% | 269 |
|
|
2023
Q4 | $4.63K | Hold |
59,272
| – | – | ﹤0.01% | 443 |
|
|
2023
Q3 | $9.18K | Buy |
59,272
+600
| +1% | +$93 | ﹤0.01% | 513 |
|
|
2023
Q2 | $13.9K | Buy |
58,672
+2,001
| +4% | +$473 | ﹤0.01% | 525 |
|
|
2023
Q1 | $22.1K | Sell |
56,671
-125
| -0.2% | -$49 | ﹤0.01% | 328 |
|
|
2022
Q4 | $9K | Buy |
56,796
+293
| +0.5% | +$46 | ﹤0.01% | 488 |
|
|
2022
Q3 | $11K | Buy |
56,503
+4,045
| +8% | +$787 | ﹤0.01% | 522 |
|
|
2022
Q2 | $27K | Buy |
52,458
+12,320
| +31% | +$6.34K | ﹤0.01% | 315 |
|
|
2022
Q1 | $24K | Buy |
+40,138
| New | +$24K | ﹤0.01% | 179 |
|